Nathalie Adda, Senior VP & Chief Medical Officer at ENANTA PHARMACEUTICALS INC (ENTA), sold 22,587 shares at $87.60 ($1.9M) on 2021-12-01, disclosed to the SEC on 2021-12-03.
Open-market sale of $1.9M ENTA by Senior VP & Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $84.81 | 1,587 | $135K | 6.9% |
| 2 | $84.81 | 1,587 | $135K | 6.9% |
| 3 | $85.49 | 5,736 | $490K | 25.2% |
| 4 | $85.49 | 5,736 | $490K | 25.2% |
| 5 | $86.45 | 2,700 | $233K | 12.0% |
| 6 | $87.60 | 1,500 |
| $131K |
| 6.7% |
| 7 | $87.68 | 842 | $74K | 3.8% |
| 8 | $88.31 | 900 | $79K | 4.1% |
| 9 | $89.33 | 899 | $80K | 4.1% |
| 10 | $89.33 | 899 | $80K | 4.1% |
| 11 | $90.17 | 201 | $18K | 0.9% |
| Total | $86.19 avg | 22,587 | $1.9M | 100% |
| Filing → |
| ENTA | SELL | 2022-01-13 | $1.8M | — | Filing → |
| ENTA | SELL | 2021-11-02 | $1.6M | — | Filing → |
| ENTA | SELL | 2021-10-13 | $2.5M | — | Filing → |